Multivitamins lack evidence to support benefit for elderly, finds review

Related tags Dietary supplement

There is currently not enough evidence to suggest that multivitamin
and mineral supplements prevent infections in elderly people,
according to a meta-analysis published on the BMJ website today.

The trials reviewed do not include research published in JAMA​ last year, which found nursing home residents supplemented with vitamin E were 20 per cent less likely to get a cold and also had less colds over the study period than a placebo group.

However in a search of medical journals up to January 2004, the UK researchers found only eight trials that met the inclusion criteria of being randomized, placebo controlled studies that evaluated a combination of multivitamins and mineral supplements in an elderly population. They also had to report an infection-related outcome.

Variability between these studies was considerable with respect to duration of follow-up, infections assessed and number of subjects, noted Alexander Sutton from the University of Leicester and Alia El-Kadiki from the Royal Hallamshire hospital in Sheffield.

Three trials reported mean difference of number of days spent with infections on multivitamins and minerals compared with placebo over 12 months. All three show a significant reduction in days of infection for the multivitamin and mineral group and the pooled estimate of a benefit of around 17.5 days, write the researchers.

However taking into account other outcomes, such as infection incidence in the vitamin groups, and reporting of adverse events, which was poor in all studies, the researchers concluded that overall the evidence was of poor to moderate quality and conflicting.

The findings are significant because the number of elderly people in developed nations is one of the fastest growing population segments. People over the age of 65 are set to make up a quarter of the total European population by 2020. The most dramatic demographic changes for the future will be in the oldest age group (80 years and over) that is estimated to grow from 21.4 million in 2000 to 35 million in 2025.

This population group is also more prone to infection and researchers have been increasingly looking at whether certain nutrients can lower this risk.

The authors add however that "the results of this review are sufficiently encouraging to warrant further and more expansive studies in this area of considerable public health importance"​.

Related news

Show more

Related products

show more

Innovation in convenient formats: vegan gummies

Innovation in convenient formats: vegan gummies

Content provided by Cambridge Commodities | 05-Mar-2024 | Product Brochure

Supplements and vitamins in pill form have been around for decades, but consumers are now seeking alternatives that fit with their busy lifestyles and...

Healthy ageing: a food supplement from Biofarma Group

Healthy ageing: a food supplement from Biofarma Group

Content provided by Biofarma Group | 26-Feb-2024 | White Paper

Worldwide, the percentage of people over 65 and 80 years of age is steadily increasing. However, as society continues to age, people do not necessarily...

Unlock the business potential of the protein trend

Unlock the business potential of the protein trend

Content provided by Valio | 24-Jan-2024 | White Paper

Read our white paper to learn how to overcome taste and texture challenges in protein products — and how to commercialise the protein trend by making delicious...

Related suppliers

Follow us

Products

View more

Webinars